Early urine electrolyte patterns in patients with acute heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
02 2019
Historique:
received: 22 06 2018
revised: 23 08 2018
accepted: 30 08 2018
pubmed: 9 10 2018
medline: 16 3 2019
entrez: 9 10 2018
Statut: ppublish

Résumé

We conducted a prospective study of emergency department (ED) patients with acute heart failure (AHF) to determine if worsening HF (WHF) could be predicted based on urinary electrolytes during the first 1-2 h of ED care. Loop diuretics are standard therapy for AHF patients. A subset of patients hospitalized for AHF will develop a blunted natriuretic response to loop diuretics, termed diuretic resistance, which often leads to WHF. Early detection of diuretic resistance could facilitate escalation of therapy and prevention of WHF. Patients were eligible if they had an ED AHF diagnosis, had not yet received intravenous diuretics, had a systolic blood pressure > 90 mmHg, and were not on dialysis. Urine electrolytes and urine output were collected at 1, 2, 4, and 6 h after diuretic administration. Worsening HF was defined as clinically persistent or WHF requiring escalation of diuretics or administration of intravenous vasoactives after the ED stay. Of the 61 patients who qualified in this pilot study, there were 10 (16.3%) patients who fulfilled our definition of WHF. At 1 h after diuretic administration, patients who developed WHF were more likely to have low urinary sodium (9.5 vs. 43.0 mmol; P < 0.001) and decreased urine sodium concentration (48 vs. 80 mmol/L; P = 0.004) than patients without WHF. All patients with WHF had a total urine sodium of <35.4 mmol at 1 h (100% sensitivity and 60% specificity). One hour after diuretic administration, a urine sodium excretion of <35.4 mmol was highly suggestive of the development of WHF. These relationships require further testing to determine if early intervention with alternative agents can prevent WHF.

Identifiants

pubmed: 30295437
doi: 10.1002/ehf2.12368
pmc: PMC6351901
doi:

Substances chimiques

Biomarkers 0
Diuretics 0
Sodium 9NEZ333N27

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-88

Informations de copyright

© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

Pharmacotherapy. 2016 Aug;36(8):852-60
pubmed: 27393709
JACC Heart Fail. 2017 Jan;5(1):1-13
pubmed: 28034373
JAMA Cardiol. 2017 Sep 1;2(9):950-958
pubmed: 28700781
Eur Heart J. 2014 May 14;35(19):1284-93
pubmed: 24585267
Lancet. 2013 Jan 5;381(9860):29-39
pubmed: 23141816
Nat Rev Cardiol. 2015 Mar;12(3):184-92
pubmed: 25560378
Eur J Heart Fail. 2014 Nov;16(11):1230-40
pubmed: 25287144
N Engl J Med. 2011 Jul 7;365(1):32-43
pubmed: 21732835
ESC Heart Fail. 2019 Feb;6(1):80-88
pubmed: 30295437
Eur J Clin Pharmacol. 1993;44 Suppl 1:S63-8
pubmed: 8486149
N Engl J Med. 2011 Mar 3;364(9):797-805
pubmed: 21366472
Clin Res Cardiol. 2016 Jun;105(6):489-507
pubmed: 26615605
Circulation. 1965 Aug;32:223-31
pubmed: 14340948
J Am Soc Nephrol. 2017 Nov;28(11):3414-3424
pubmed: 28739647
Am Heart J. 2005 Feb;149(2):209-16
pubmed: 15846257
Eur J Heart Fail. 2017 Nov;19(11):1390-1400
pubmed: 28836359
Circ Heart Fail. 2015 Jul;8(4):741-8
pubmed: 26041600
Ann Emerg Med. 2014 Sep;64(3):292-8
pubmed: 24746846
Int J Emerg Med. 2017 Dec;10(1):17
pubmed: 28484958
J Card Fail. 2018 Jun;24(6):349-354
pubmed: 29410227
Am Heart J. 2015 Aug;170(2):313-21
pubmed: 26299229
Circ Heart Fail. 2016 Jan;9(1):e002370
pubmed: 26721915
JACC Heart Fail. 2015 Oct;3(10):737-47
pubmed: 26449993
N Engl J Med. 2017 May 18;376(20):1956-1964
pubmed: 28402745

Auteurs

Sean P Collins (SP)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Cathy A Jenkins (CA)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Adrienne Baughman (A)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Karen F Miller (KF)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Alan B Storrow (AB)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Jin H Han (JH)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Nancy J Brown (NJ)

Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.

Dandan Liu (D)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

James M Luther (JM)

Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Internal Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Internal Medicine, Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA.

Candace D McNaughton (CD)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Wesley H Self (WH)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Dungeng Peng (D)

Department of Internal Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.

Jeffrey M Testani (JM)

Department of Internal Medicine, Division of Cardiology, Yale University, New Haven, CT, USA.

JoAnn Lindenfeld (J)

Department of Internal Medicine, Division of Cardiology, Vanderbilt University Medical Center, Nashville, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH